Pain News and Research

Latest Pain News and Research

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a Prior Approval Supplement for EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII.

4 Nov 2013

Generic drug gabapentin appears to be safe, effective in treating alcohol dependence

The generic drug gabapentin, which is already widely prescribed for epilepsy and some kinds of pain, appears to be safe and effective in the treatment of alcohol dependence. The finding comes from a 150-patient randomized, placebo-controlled, double blind clinical trial conducted by scientists at The Scripps Research Institute.

4 Nov 2013

FzioMed receives FDA approval for independent review of PMA for Oxiplex Gel

FzioMed, a medical device company that recently celebrated the 17th anniversary of its founding, has received approval from the Commissioner of the U.S. Food and Drug Administration of its Petition for an independent review of its premarket approval application for Oxiplex Gel.

4 Nov 2013

Even light consumption of alcohol with acetaminophen can increase risk of kidney dysfunction

New research finds that the combination of acetaminophen paired with alcohol — even if consumed moderately or lightly — can increase the risk of kidney dysfunction, according to new research released today at the American Public Health Association's 141st Annual Meeting in Boston.

4 Nov 2013

Experimental drug effective in treating patients with non-small cell lung cancer

An experimental cancer drug that has shown promise in the treatment of melanoma has also shown early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death among men and women worldwide.

4 Nov 2013

$IOF outlines guidelines to help prevent osteoporosis and fractures in cancer patients$

IOF outlines guidelines to help prevent osteoporosis and fractures in cancer patients

Cancer is a health burden of increasing importance which affects close to 13 million people globally. Bone is often affected in these patients, frequently because of bone metastases, or as a result of anti-cancer therapies which can contribute to bone loss and fragility.

4 Nov 2013

Absence of vision from birth leads to permanent state of pain hypersensitivity, shows report

Absence of vision from birth leads to a permanent state of pain hypersensitivity, reports PAIN. An international team of scientists investigated whether congenitally blind subjects experience pain differently than sighted individuals. Their results, published in the current issue of PAIN®, reveal compelling evidence that congenitally blind individuals are hypersensitive to pain caused by thermal stimuli.

3 Nov 2013

Tips for combating fall allergies

Fall allergies and rapidly changing temperatures send many people reaching for pain relievers or other remedies to deal with runny noses and other symptoms associated with sinus and allergy problems.

31 Oct 2013

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD Pharmaceuticals, Inc. today announced that it is temporarily suspending the marketing and commercial distribution of Iclusig® (ponatinib), a treatment for patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL), in the United States, while it continues to negotiate updates to the U.S. prescribing information for Iclusig and implementation of a risk mitigation strategy.

31 Oct 2013

MEDNAX reports revenue growth of 17.3% to $555M

MEDNAX, Inc., the national medical group specializing in neonatal, maternal-fetal, pediatric cardiology, other pediatric subspecialties and anesthesia physician services, today reported earnings of $1.52 per share for the three months ended September 30, 2013 resulting from strong revenue growth, primarily from recent acquisitions.

31 Oct 2013

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

Protego Medical Pty Ltd, an early stage medical technology company developing a medical device for sternal protection during cardiac surgery, was launched today with AU$2M start-up financing from Australia’s Medical Research Commercialisation Fund (MRCF). At the same time, the Company announced the appointment of Pablo Solis as CEO.

31 Oct 2013

Changing the lighting patterns in hospital rooms can improve patient care

A new study suggests that changing the lighting patterns in hospital rooms so that they're more aligned with normal sleep-wake cycles could help patients feel better with less fatigue and pain.

30 Oct 2013

Once-daily prescription medicine for COPD now available throughout the U.S.

GlaxoSmithKline plc and Theravance, Inc. today announced that BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease, is now available to pharmacies throughout the U.S.

30 Oct 2013

CME Medical helps healthcare professionals to gain confidence in end of life and palliative care

CME Medical, is helping healthcare professionals to gain confidence in caring for patients at the end of their lives. Managing end of life care is a challenge for all health staff, as it often involves dealing with complex and emotional communication with patients and relatives and managing patient symptoms. But now highly sophisticated mannequins – which can talk and simulate signs and symptoms of advanced illness – are being used in a pioneering and unique training programme in Birmingham.

30 Oct 2013

Findings point to simple way to potentially improve patient care

A new study suggests that changing the lighting patterns in hospital rooms so that they’re more aligned with normal sleep-wake cycles could help patients feel better with less fatigue and pain.

30 Oct 2013

High-definition transcranial direct current stimulation helps treat pain in fibromyalgia patients

Imagine significantly reducing a persistent migraine or fibromyalgia by a visit to a doctor who delivers low doses of electricity to the brain.

30 Oct 2013

Viewpoints: Policy cancellations raising ire; One woman's story on more affordable insurance; Daschle: Democrats want deal on entitlements

The insurers have assumed that everyone would be required to have coverage by March 31. If the enrollment period is extended for a significant period, the sickest people are most likely to sign up early and the healthiest will likely hang back, driving up the costs ... there is no need for despair. In the long run, the technical problems can and will be fixed and most Americans will be better off.

30 Oct 2013

Promising melanoma drug demonstrates potential for non-small cell lung cancer treatment

An experimental new cancer drug called MK-3475, which has shown dramatic promise for treating melanoma is also showing early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death of men and women worldwide.

30 Oct 2013

DJO Global and Olympic gold medalist team up to educate athletes on injury prevention

DJO Global, Inc. today announced that Megan Rapinoe, Olympic gold medalist for the U.S. Women's Soccer Team and member of the Seattle Reign FC, a part of the National Women's Soccer League, is partnering with the medical device company to help educate young athletes on the value of bracing in both injury prevention and returning to play.

30 Oct 2013

New headpiece can improve brain stimulation technique to treat depression

A brain stimulation technique that is used to treat tough cases of depression could be considerably improved with a new headpiece designed by University of Michigan engineers.

30 Oct 2013

Pain News and Research

Latest Pain News and Research

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Generic drug gabapentin appears to be safe, effective in treating alcohol dependence

FzioMed receives FDA approval for independent review of PMA for Oxiplex Gel

Even light consumption of alcohol with acetaminophen can increase risk of kidney dysfunction

Experimental drug effective in treating patients with non-small cell lung cancer

IOF outlines guidelines to help prevent osteoporosis and fractures in cancer patients

Absence of vision from birth leads to permanent state of pain hypersensitivity, shows report

Tips for combating fall allergies

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

MEDNAX reports revenue growth of 17.3% to $555M

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

Changing the lighting patterns in hospital rooms can improve patient care

Once-daily prescription medicine for COPD now available throughout the U.S.

CME Medical helps healthcare professionals to gain confidence in end of life and palliative care

Findings point to simple way to potentially improve patient care

High-definition transcranial direct current stimulation helps treat pain in fibromyalgia patients

Viewpoints: Policy cancellations raising ire; One woman's story on more affordable insurance; Daschle: Democrats want deal on entitlements

Promising melanoma drug demonstrates potential for non-small cell lung cancer treatment

DJO Global and Olympic gold medalist team up to educate athletes on injury prevention

New headpiece can improve brain stimulation technique to treat depression

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Pain News and Research

Latest Pain News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in